A detailed history of Baystate Wealth Management LLC transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Baystate Wealth Management LLC holds 2,000 shares of AMRN stock, worth $1,180. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,000
Holding current value
$1,180
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 29, 2024

BUY
$0.66 - $0.91 $1,320 - $1,820
2,000 New
2,000 $1,000
Q2 2020

Jul 28, 2020

SELL
$4.78 - $8.26 $3,346 - $5,782
-700 Closed
0 $0
Q4 2019

Jan 21, 2020

BUY
$13.94 - $24.12 $9,758 - $16,884
700 New
700 $15,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $238M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Baystate Wealth Management LLC Portfolio

Follow Baystate Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baystate Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baystate Wealth Management LLC with notifications on news.